Utility of Self-Rated vs. Informant-Rated Ascertain Dementia-8 for Detection of Early Cognitive Impairment: Experience of a “Real-World” Memory Clinic

Article information

Ann Geriatr Med Res. 2026;30(1):109-119
Publication date (electronic) : 2025 November 27
doi : https://doi.org/10.4235/agmr.25.0082
1Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore
2Institute of Geriatrics and Active Ageing, Tan Tock Seng Hospital, Singapore
3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
Corresponding Author: Khin Khin Win, MRCP Department of Geriatric Medicine, Tan Tock Seng Hospital, Annex 2, Level 3, 11 Jalan Tan Tock Seng, Singapore 308433 Email: khin.win.khin@nhghealth.com.sg
Received 2025 May 29; Revised 2025 November 7; Accepted 2025 November 26.

Abstract

Background

The Ascertain Dementia 8-item Questionnaire (AD8) is a validated informant-based interview for early dementia detection. Research suggests the utility of self-rated AD8 to identify milder dementia forms in research settings. This study compares the factor structure, reliability, and diagnostic performance between AD8-Self and AD8-Informant for early cognitive impairment (ECI) in a clinical setting.

Methods

Five hundreds fifteen patient-informant dyads (43 cognitively intact and 472 ECI) from a tertiary memory clinic completed both self and informant-reported AD8. We conducted exploratory factor analysis to determine the factor structure, Cronbach’s alpha for internal consistency, and receiver operating characteristic (ROC) curve analysis for ECI, including a subgroup analysis for mild cognitive impairment (MCI).

Results

The mean age and education of ECI participants were 75.61 years (range, 51–95) and 5.6 years (range, 0–20), respectively, and 72.6 years (range, 51–89) and 6.8 years (range, 0–16) in the MCI subgroup. Unlike AD8-Informant’s one-factor structure, AD8-Self had a two-factor structure corresponding to memory and non-memory domains. AD8-Self demonstrated lower reliability (Cronbach’s alpha: ECI 0.666 vs. 0.764; MCI 0.663 vs. 0.709). In ECI, AD8-Informant (cutoff score ≥3) showed better diagnostic performance (sensitivity 89%, specificity 79%) than AD8-Self (cutoff score ≥4; sensitivity 27.1%, specificity 95.3%) (AUC 0.915 vs. 0.593; p<0.001). Similar results were found in MCI (sensitivity 64.7% vs. 26.5%; specificity 79.1% vs. 95.3%; AUC 0.745 vs. 0.600; p=0.002).

Conclusion

AD8-Self has a distinct factor structure, lower reliability, and inferior diagnostic performance compared to AD8-Informant for ECI/MCI detection. Our result do not support AD8-Self as a standalone tool for detecting ECI or MCI.

INTRODUCTION

More than 55 million people currently live with dementia worldwide, with over 60% residing in low- and middle-income countries.1) Nearly 10 million new cases are diagnosed annually, making dementia a major global public health priority. In line with the global trend of increasing dementia prevalence due to population aging, the prevalence of dementia in Singapore was reported to be 8.8% among older persons aged 60 and above, according to the second Well-Being of the Singapore Elderly (WISE) study (2023).2)

Aligned with the Global Action Plan on the Public Health Response to Dementia 2017–2025, Singapore’s National Dementia Strategy emphasizes timely diagnosis and post-diagnostic support for persons living with dementia and their caregivers. As the diagnosis of dementia remains clinical in nature, identifying intra-individual cognitive and functional decline from baseline—based on input from reliable informants and objective cognitive testing—remains the cornerstone for early diagnosis and disease staging.3) This underscores the need for assessment tools with strong diagnostic performance and reliability that are also easy to administer and feasible for use in clinical practice.

The Washington University AD8 (Ascertain Dementia 8-item Informant Questionnaire) is a brief tool that captures subjective cognitive symptoms via informants. Initially designed to distinguish early dementia from normal cognition, it assesses intra-individual changes in memory (e.g., consistent memory problems, repetition, forgetting appointments), temporal orientation, judgment (e.g., decision-making, managing finances), and function (e.g., reduced interest in activities, difficulty using appliances).4) It has been translated and validated across multiple languages and regions, including Asia.5-12) Though originally an informant-based screening tool, the AD8 was later evaluated as a self-rated questionnaire, showing utility in differentiating at-risk individuals from those without dementia, particularly in mild cases.12,13) While informant-based assessments offer a longitudinal estimate of cognitive change, self-rated assessments may be particularly useful when informants are unavailable or when older adults prefer to maintain their privacy of not disclosing the assessment outcome to their family members.14,15) However, prior studies indicate a performance gap between the informant-reported (AD8-Informant) and self-reported (AD8-Self) versions,16,17) with AD8-Informant generally providing better screening accuracy at a cutoff score of ≥2.

While many studies support the utility of either AD8-Informant or AD8-Self as sensitive and reliable tools to differentiate non-demented from demented individuals,7,8,13,14,18) some report that AD8-Informant offers more accurate results.16,17,19) Locally, findings have been mixed. One study reported AD8-Self effective in identifying mild cognitive impairment (MCI) and early dementia at a memory clinic,12) whereas others emphasized stronger performance of AD8-Informant in distinguishing cognitive impairment and dementia.17,20,21) Differences in study setting (clinic vs. community), participants’ characteristics, or the expertise of test administrator may account for these inconsistencies. Moreover, inconsistent cutoff scores across different versions and settings hinder consensus on the optimal threshold for identifying cognitively impaired individuals (Table 1).22-27) Most studies focus on the utility of AD8-Informant and AD8-Self to distinguish cognitively impaired from unimpaired individuals. While Wang et al.5) demonstrated a one-factor model for AD8-Informant, the factor structure of the informant and self-rated versions has not yet been compared.

Summary of studies on AD8 performance and factor structure in Asian population

Therefore, this study aimed to compare the diagnostic performance and reliability of AD8-Self and AD8-Informant in identifying early cognitive impairment (ECI)—MCI and mild dementia—with optimal cutoff scores for each version in a predominantly Chinese Asian population of healthy older persons attending a tertiary memory clinic. Additionally, we compared the factor structures of AD8-Self and AD8-Informant, which may help explain differences in diagnostic performance.

MATERIALS AND METHODS

Study Design and Participants

This cross-sectional study involved 515 participant–informant dyads of community-dwelling older adults with ECI, defined as MCI or dementia with a Clinical Dementia Rating (CDR) score of 0.5 to 1.28) Participants were recruited from the Memory Clinic at the Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore, between January 2011 and December 2013. Clinicians at the clinic were trained in using informant-based tools, including the CDR and AD8 questionnaire, for ECI evaluation.

We studied participant–informant dyads in which participants were aged 55 years and older and were diagnosed with MCI, very mild or mild dementia (CDR global score 0.5–1). Individuals with a CDR score of ≥2 were excluded, as individuals with moderate to severe dementia typically have limited insight and are unlikely to provide reliable self-assessment of their cognitive status. This study is a secondary analysis of a previously approved “Memory Clinic Service Standing Database” (SDB-2022-0056-TTSH-01), maintained by the Cognition and Memory Disorder Service. Ethics approval was waived by the National Healthcare Group Domain Specific Review Board for use of fully anonymized data. The database, collected between 2009 and 2017, includes participants’ demographic data, comorbidities, medication history, cognitive and functional assessments, neuropsychological and neuropsychiatric data, neuroimaging results, informant characteristics, and caregiver burden scores.

Assessment

All participants underwent a comprehensive assessment by a nurse clinician and a doctor, followed by blood tests and neuroimaging. Participants with subtle cognitive complaints, but not yet fulfilling diagnostic criteria for dementia syndrome received standardized, locally validated neuropsychological assessments by neuropsychologists; 67.8% of study participants completed these assessments.

Cognitive diagnoses, including severity and etiology, were determined through consensus meetings involving geriatricians, neuropsychologists, and trained nurse clinicians. The clinical diagnosis of dementia was based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria and it is to note that diagnosis of dementia was established purely based on clinical history. Classification of etiology was made using international published criteria for dementia:

(1) Alzheimer’s disease: National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria,29)

(2) Vascular and mixed dementia: National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherche et l’Enseignement en Neurosciences (NINDS-AIREN),30)

(3) Frontotemporal lobar degeneration: consensus clinical criteria,31) and

(4) Parkinson’s disease dementia: established clinical diagnostic criteria.32)

MCI was diagnosed using the revised Petersen criteria.33) Cognitive impairment severity was rated using the locally validated CDR scale,34) where 0 indicated normal cognition; 0.5, MCI or very mild dementia; and 1, 2, and 3 represented mild, moderate, and severe dementia, respectively. This study included participants with CDR scores of 0–1 and excluded those with scores ≥2.

Measurements and Instruments

Baseline demographics for both participants and informants were collected, including age, sex, education, ethnicity, and relationship to the participant. Trained nurse clinicians or geriatricians administered both self-reported and informant-reported AD8 questionnaires. Participants underwent locally validated cognitive screening assessment: Abbreviated Mental Test (AMT), a 10-question cognitive screening instrument which assesses the orientation, memory (immediate memory with delayed recall) and attention,35) modified Chinese Mini-Mental State Examination (m-CMMSE),35) and modified Chinese Frontal Lobe Assessment Battery (m-CFAB).36) The participants were also assessed for their function via modified Barthel Index for basic activities of daily living (BADL)37) and the Lawton and Brody’s instrumental activities of daily living scale (IDAL),38) mood disorders using the DSM-IV criteria for major depressive disorder and neuropsychiatric symptoms using the Neuropsychiatric Inventory-Questionnaire (NPI-Q).39) Where applicable, participants received standardized, locally validated neuropsychological assessment battery, including word list memory (immediate recall, delayed recall and recognition), verbal fluency (animal category), constructional praxis test, the modified Boston Naming Test, the Welchsler Adult Intelligence Scale-Revised (WAIS-R) subtest of block design and object assembly which measures visuospatial and non-verbal reasoning abilities.40)

Statistical Analysis

Descriptive and inferential statistical analyses were conducted using IBM SPSS version 27.0 (IBM, Armonk, NY, USA). Chi-square tests were used for categorical variables, and one-way analysis of variance (ANOVA) with Bonferroni correction for post hoc comparisons of continuous variables. All tests were two-sided, with a significance level set at p<0.05.

Receiver operating characteristic (ROC) curves were used to compare the diagnostic performance of AD8-Self and AD8-Informant, using clinical diagnosis (normal/MCI/ECI) as the reference standard. Areas under the ROC curves (AUCs) were compared using the DeLong method to demonstrate that the difference in AUCs of AD8-Self and AD8-Informant were statistically significant.41) Optimal cutoff values were determined using the Youden index (sensitivity+specificity–1),42) and diagnostic performance was evaluated by calculating sensitivity, specificity, positive predictive value, and negative predictive value. Internal consistency was assessed using Cronbach’s alpha.

Exploratory factor analysis was performed to examine the factor structures of AD8-Self and AD8-Informant. Sampling adequacy was evaluated with the Kaiser-Meyer-Olkin (KMO) statistic, and the Bartlett test of sphericity was used to determine the suitability of performing factor analysis. Principal component analysis with varimax rotation was used to extract factors, and parallel analysis to determine the optimal number of factors to retain. Items with factor loadings below 0.5 were excluded.43)

RESULTS

Demographic and Clinical Characteristics

This study included 515 participant–informant dyads, predominantly of Chinese ethnicity. Among these, 43 were cognitively normal, while 472 participants had ECI, comprising 102 participants with MCI (CDR=0.5) and 370 with mild dementia (CDR 0.5–1.0). The mean age of the total cohort was 75.08±7.16 years, and 58.8% were female. Participants with normal cognition were slightly younger (mean age: 69.28±7.87 years) and had more years of formal education (9.58±4.83 years) compared to those with ECI (75.61±6.9 years and 5.6±4.9 years, respectively) (Table 2).

Baseline characteristics of study cohort (n=515)

As expected, cognitively normal participants scored higher on cognitive and functional assessments. Among participants with ECI, the mean AMT and m-CMMSE scores were 7.0±2.2 and 19.1±4.8, respectively. The mean AD8-Self scores were 1.74±1.2 in the normal cognition group and 2.4±1.8 in the ECI group. Corresponding AD8-Informant scores were 1.67±1.25 and 5.29±2.04, respectively. Participants with ECI exhibited relatively preserved BADLs, with a Barthel Index score of 96.45±7.1, while experiencing some degree of impairment in IADLs, with a Lawton and Brody’s IADL score of 15.1±4.8 (Table 2).

Diagnostic Performance of AD8-Self and AD8-Informant with Cutoff Scores

ROC analysis was used to compare the diagnostic performance of AD8-Self and AD8-Informant for detecting ECI. The AD8-Informant demonstrated significantly superior diagnostic performance, with an optimal cutoff score of ≥3, yielding a sensitivity of 89.0%, specificity of 79.1%, and AUC of 0.915. In contrast, AD8-Self demonstrated a significantly lower performance, with an optimal cutoff score ≥4, sensitivity of 27%, specificity of 95.3%, and an AUC of 0.593 (p<0.001) (Table 3, Fig. 1A).

Reliability and diagnostic performance of AD8-Self vs. AD8-Informant

Fig. 1.

Comparison of AUC of AD8-Self versus AD8-Informant between two groups: (A) early cognitive impairment, (B) mild cognitive impairment. AUC, area under the curve; AD8-Self, Ascertain Dementia 8-item Questionnaire-Self reported; AD8-Informant, Ascertain Dementia 8-item Questionnaire-Informant reported.

Similar findings were observed in the MCI subgroup. AD8-Informant achieved a sensitivity of 64.7%, specificity of 79.1%, and AUC of 0.745 (cutoff score ≥3), whereas AD8-self had a sensitivity of 26.5%, specificity of 95.3%, and AUC of 0.600 (cutoff score ≥4) (p=0.002) (Table 3, Fig. 1B).

Reliability of AD8-Self and AD8-Informant

The internal consistency of AD8-Informant was higher than that of AD8-Self, as measured by Cronbach’s alpha. For the overall ECI group, Cronbach’s alpha was 0.764 for AD8-Informant and 0.666 for AD8-Self. In the MCI subgroup, values were 0.709 and 0.663, respectively (Table 3).

Factor Analysis of AD8-Self and AD8-Informant

Factor analysis was deemed appropriate for both AD8-Self and AD8-Informant, with KMO statistics of 0.742 and 0.85, respectively, and significant Bartlett’s test of sphericity (χ²=457.8 and 764.39, respectively; p<0.0001) (Table 4).

Factor structure of AD8-Self vs. AD8-Informant

For AD8-Self, principal component analysis and parallel analysis supported a two-factor structure, accounting for 44.69% of the total variance. The first factor (30.11% of variance) included three items related to non-memory domains: less interest in hobbies/activities, trouble learning how to use tools or gadgets, and difficulty handling complicated financial affairs. The second factor (14.58% of variance) encompassed memory-related items: daily problems with thinking and/or memory, trouble remembering appointments, and repeating the same thing over and over. Two items, “forgetting the correct week, month, or year” and “problems with judgment,” were excluded due to low factor loadings (0.447 and 0.487, respectively).

In contrast, parallel analysis recommended a one-factor structure for AD8-Informant, which accounted for 38.58% of the total variance. All items showed strong loadings on this single factor.

DISCUSSION

This study compared the diagnostic performance of AD8-Self with AD8-Informant to evaluate the utility of AD8-Self as a standalone screening tool in detecting ECI in clinical settings. Although AD8-Self has shown potential in previous research, there are studies emphasizing better diagnostic performance of AD8-Informant. Although AD8 has been validated in several Asian countries, most studies focused on the performance of AD8-Self or AD8-Informant, with only a few studies comparing the performance of both tools.16,17,22) Our study comprehensively investigated the diagnostic performance of both tools; optimal cutoff scores, and reliability in differentiating early cognitively impaired older individuals (with a subgroup of MCI) from cognitively unimpaired individuals in a tertiary memory clinic. The added strength of our study is to explore the factor structures of AD8-Self and AD8-Informant. To our knowledge, this is the first study to analyse the factor structures of both assessment. Our finding demonstrate that AD8-Self has significantly poorer discriminant ability in identifying both ECI and MCI, with AUCs of 0.593 and 0.600, respectively. AD8-Informant performed better across all metrics and showed a one-factor structure, while AD8-Self demonstrated a two-factor structure.

First, the optimal cutoff score in our study was ≥3 for AD8-Informant and ≥4 for AD8-Self to identify individuals with ECI, higher than previous reports—e.g., ≥2 and ≥1, respectively, by Galvin et al.4,13) and a local study by Chin et al.12) These discrepancies may reflect differences in study settings (community vs. clinic), demographic characteristics, such as age, educational level, and the severity of cognitive impairment. Our sample comprised older individuals with lower educational attainment and included only MCI and mild dementia cases, while other studies included ECI as well as moderate to severe dementia. The variation raises question about whether factors like age and education influence the performance of AD8. While Galvin et al.18) indicated that AD8-Informant was not likely to be influenced by age, education, or cultural differences, this was not the case in a study by Cai et al.,9) which showed education affected AD8-Self in a community dwelling older Chinese populations.

Second, our results highlighted AD8-Self’s reduced discriminant ability more pronounced in ECI (AUC 0.915 vs. 0.593) than in MCI (AUC 0.745 vs. 0.600), which is likely attributable to anosognosia, a neurological symptom characterized by limited awareness of one’s cognitive and functional deficits, commonly seen in individuals with cognitive impairment. This lack of insight into their changes in memory and cognition can cause underreporting of their symptoms.44,45) Therefore, in the absence of reliable informants, clinicians should consider supplementing self-reported AD8 with other objective cognitive assessments or performance-based tools, including neuropsychological testing, as recommended by Lim et al.46) Still, the high specificity of AD8-Self may make it useful in the very early stage of cognitive impairment; a positive result should prompt further evaluation and follow-up, in line with Gao et al.’s recommendation.47)

Third, although both AD8 versions showed strong performance, the performance in the ECI group was much higher than in the MCI group. This can be attributed to the subtle nature of cognitive changes in MCI, which may not be easily noticeable to informants. In contrast, individuals with dementia typically exhibit more noticeable cognitive symptoms, which informants or caregivers can identify. Informants may also underestimate the severity of cognitive symptoms or may not be aware of certain cognitive deficits in individuals with subtle changes in MCI group. Additionally, informant characteristics—such as gender, education, and contact frequency—can influence reporting accuracy which may impact the diagnostic performance of informant-based assessment tools. Studies have shown that female caregivers are often more likely to assume primary caregiving role and attuned to behavioural, cognitive and functional changes.48,49) These sociodemographic factors may partially explain the weaker performance of AD8-Informant in the MCI subgroup, although our study did not explore these directly.

Fourth, our findings align with those of Li et al.11) and Dong et al.17) showing that AD8-Informant has stronger reliability with higher Cronbach’ alpha values. Due to the lack of insight, which is commonly seen in individuals with cognitive impairment, the reliability of AD8-Self may be questionable. Despite its lower reliability, AD8-Self still showed acceptable internal consistency (Cronbach’s alpha: 0.666 for ECI and 0.663 for MCI), suggesting that individuals with ECI can still recognize their cognitive and/or functional decline to a certain extent, although their insight may be limited. Another important observation is that the Cronbach’s alpha for AD8-Informant in our study was lower than in Galvin’s original study18) and other Asian studies,6,7,16) possibly reflecting differences in clinical setting, cultural difference between Asian and Western populations and test administrator of the tools. In our study, assessments were administered by memory clinic physicians and nurse clinicians.

Additionally, our study provides insight into the distinct factor structures of AD8-Self versus AD8-Informant: AD8-Informant showed a unidimensional structure, consistent with prior work,50) while AD8-self displayed two factors reflecting memory and non-memory domains. One possible explanation for this could be that individuals with ECI may not associate cognitive decline with functional issues or may attribute cognitive changes to aging and functional changes to other physical health conditions, leading to a dissociation between cognitive and functional symptoms. Prior studies on the factor structure of AD8-Informant are limited and this is the first study, to our knowledge, to highlight structural differences between self- and informant-rated AD8s (two vs. one factor).

Our study has several limitations. Firstly, AD8 was originally designed for community screening, our study was, however, conducted in a tertiary memory clinic, resulting in a relatively smaller number of cognitively normal participants compared to the ECI group. It could introduce spectrum bias and limit generalizability to community-dwelling populations. Secondly, we recognise that our data was collected a decade ago, and findings should be further validated in newer cohorts. Finally, despite identifying a distinct factor structure for AD8-Self, we did not analyse correlations between AD8-Self’s factor structure and cognitive severity or assess the impact of participant demographics on test performance.

In conclusion, AD8-Self demonstrated inferior sensitivity and reliability compared to AD8-Informant in detecting ECI. Our findings suggest that AD8-Self alone may be insufficient for clinical screening without collateral input or additional objective cognitive testing. In clinical settings, collateral history from a reliable informant remains an integral role in confirming the degree of cognitive decline and functional impairment. In situations where informants are unavailable, we recommend that clinicians base their evaluations and judgement on objective cognitive assessments, incorporating neuropsychological testing when clinically indicated. The differing factor structures of the two versions underscore the need for further research to explore how these structural variations relate to dementia severity.

Notes

We would like to thank the doctors, nurse clinicians of the Cognition and Memory Disorders Service, Department of Geriatric Medicine, Tan Tock Seng Hospital and research assistants from the Institute of Geriatrics and Active Aging, Tan Tock Seng Hospital, for their substantial contribution in data acquisition.

CONFLICT OF INTEREST

The researchers claim no conflicts of interest.

FUNDING

None.

AUTHOR CONTRIBUTIONS

Conceptualization, WSL, KKW; Data curation, WSL; Methodology, WSL, KKW; Supervision, WSL; Writing-original draft, KKW; Writing-editing & review, WSL, JC, JPL, EH, NA, MC.

References

1. World Health Organization. Dementia [Internet]. Geneva, Switzerland: World Health Organization; c2025. [cited 2025 Dec 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
2. Institute of Mental Health. The 2nd Well-Being of the Singapore Elderly (WiSE) study [Internet]. Singapore: Institute of Mental Health; 2024. [cited 2025 Dec 1]. Available from: https://www.imh.com.sg/Newsroom/News-Releases/Documents/WISE%202%20Press%20Release_28Aug_IMHFINAL.pdf.
3. Apostolova LG. Alzheimer disease. Continuum (Minneap Minn) 2016;22(2 Dementia):419–34. 10.1212/CON.0000000000000307. 27042902.
4. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, et al. The AD8: a brief informant interview to detect dementia. Neurology 2005;65:559–64. 10.1212/01.wnl.0000172958.95282.2a. 16116116.
5. Wang Y, Liu T, Cai Y, Wu Y, Nie Y, Kuang W, et al. The Chinese version of informant AD8 for mild cognitive impairment and dementia screening in community-dwelling older adults. Public Health Nurs 2023;40:258–65. 10.1111/phn.13166. 36633577.
6. Ryu HJ, Kim HJ, Han SH. Validity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia. Alzheimer Dis Assoc Disord 2009;23:371–6. 10.1097/wad.0b013e31819e6881.
7. Meguro K, Kasai M, Nakamura K. [Reliability and validity of the Japanese version of the AD8]. Nihon Ronen Igakkai Zasshi 2015;52:61–70. Japanese. 10.3143/geriatrics.52.61. 25786630.
8. Larner AJ. AD8 informant questionnaire for cognitive impairment: pragmatic diagnostic test accuracy study. J Geriatr Psychiatry Neurol 2015;28:198–202. 10.1177/0891988715573536. 25769735.
9. Cai Y, Qiu P, Wan Y, Meng SS, Liu T, Wang Y, et al. Establishing cut-off scores for the self-rating AD8 based on education level. Geriatr Nurs 2021;42:1093–8. 10.1016/j.gerinurse.2021.06.027. 34274686.
10. Dominguez JC, de Guzman MF, Joson ML, Fowler K, Natividad BP, Cruz PS, et al. Validation of AD8-Philippines (AD8-P): a brief informant-based questionnaire for dementia screening in the Philippines. Int J Alzheimers Dis 2021;2021:7750235. 10.1155/2021/7750235. 34754516.
11. Li T, Wang HL, Yang YH, Galvin JE, Morris JC, Yu X. [The reliability and validity of Chinese version of AD8]. Zhonghua Nei Ke Za Zhi 2012;51:777–80. Chinense. 23290975.
12. Chin R, Ng A, Narasimhalu K, Kandiah N. Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population. Am J Alzheimers Dis Other Demen 2013;28:284–8. 10.1177/1533317513481090. 23493722.
13. Galvin JE, Roe CM, Coats MA, Morris JC. Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Arch Neurol 2007;64:725–30. 10.1001/archneur.64.5.725. 17502472.
14. Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002;47:723–33. 10.1177/070674370204700803. 12420650.
15. Tanwani R, Danquah MO, Butris N, Saripella A, Yan E, Kapoor P, et al. Diagnostic accuracy of Ascertain Dementia 8-item questionnaire by participant and informant: a systematic review and meta-analysis. PLoS One 2023;18e0291291. 10.1371/journal.pone.0291291. 37699028.
16. Chio OI, Yip PK, Liu YC, Chen LH, Wang PC, Tsai TH, et al. Detection of cognitive impairment using self-rated AD8 and informant-reported AD8. J Formos Med Assoc 2018;117:42–7. 10.1016/j.jfma.2017.02.015. 28336001.
17. Dong Y, Pang WS, Lim LB, Yang YH, Morris JC, Hilal S, et al. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting. J Alzheimers Dis 2013;35:159–68. 10.3233/jad-122026. 23380993.
18. Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology 2006;67:1942–8. 10.1212/01.wnl.0000247042.15547.eb. 17159098.
19. Denny A, Bartley K, Edwards S, Webbe F, LoGalbo A. AD8 patient-informant discrepancy predicts insight and cognitive impairment in Alzheimer's disease. Geriatr Nurs 2021;42:262–7. 10.1016/j.gerinurse.2020.08.009. 32891442.
20. Kan CN, Zhang L, Cheng CY, Wong TY, Venketasubramanian N, Chen CL, et al. The informant AD8 can discriminate patients with dementia from healthy control participants in an Asian older cohort. J Am Med Dir Assoc 2019;20:775–9. 10.1016/j.jamda.2018.11.023. 30661859.
21. Tew CW, Ng TP, Cheong CY, Yap P. A brief dementia test with subjective and objective measures. Dement Geriatr Cogn Dis Extra 2015;5:341–9. 10.1159/000438455. 26483833.
22. Kasai M, Sugawara T, Takada J, Kumai K, Nakamura K, Meguro K. Self-reported cognitive decline based on the Ascertain Dementia 8 questionnaire may be effective for detecting mild cognitive impairment and dementia in the community: the Wakuya project. Dement Geriatr Cogn Dis Extra 2021;11:45–50. 10.1159/000514324. 33790940.
23. Yang YH, Galvin JE, Morris JC, Lai CL, Chou MC, Liu CK. Application of AD8 questionnaire to screen very mild dementia in Taiwanese. Am J Alzheimers Dis Other Demen 2011;26:134–8. 10.1177/1533317510397330. 21415088.
24. Shaik MA, Xu X, Chan QL, Hui RJ, Chong SS, Chen CL, et al. The reliability and validity of the informant AD8 by comparison with a series of cognitive assessment tools in primary healthcare. Int Psychogeriatr 2016;28:443–52. 10.1017/s1041610215001702. 26489991.
25. Chan QL, Xu X, Shaik MA, Chong SS, Hui RJ, Chen CL, et al. Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare. J Alzheimers Dis 2016;49:121–7. 10.3233/jad-150390. 26444776.
26. Kim A, Kim S, Park KW, Park KH, Youn YC, Lee DW, et al. A comparative evaluation of the KDSQ-C, AD8, and SMCQ as a cognitive screening test to be used in national medical check-ups in Korea. J Korean Med Sci 2019;34e111. 10.3346/jkms.2019.34.e111. 30977313.
27. Tak P, Rohilla J, Jhanwar S. Comparison of two screening instruments to detect dementia in Indian elderly subjects in a clinical setting. J Family Med Prim Care 2021;10:657–61. 10.4103/jfmpc.jfmpc_1050_20. 34041057.
28. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9 Suppl 1:173–8. 10.1017/s1041610297004870. 9447441.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939–44. 10.1212/wnl.34.7.939. 6610841.
30. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 1993;43:250–60. 10.1212/wnl.43.2.250. 8094895.
31. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54. 10.1212/wnl.51.6.1546. 9855500.
32. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689–837. 10.1002/mds.21507. 17542011.
33. Artero S, Petersen R, Touchon J, Ritchie K. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord 2006;22:465–70. 10.1159/000096287. 17047325.
34. Lim WS, Chin JJ, Lam CK, Lim PP, Sahadevan S. Clinical dementia rating: experience of a multi-racial Asian population. Alzheimer Dis Assoc Disord 2005;19:135–42. 10.1097/01.wad.0000174991.60709.36. 16118530.
35. Sahadevan S, Lim PP, Tan NJ, Chan SP. Diagnostic performance of two mental status tests in the older Chinese: influence of education and age on cut-off values. Int J Geriatr Psychiatry 2000;15:234–41. 10.1002/(sici)1099-1166(200003)15:3<234::aid-gps99>3.0.co;2-g. 10713581.
36. Chong MS, Lim WS, Chan SP, Feng L, Niti M, Yap P, et al. Diagnostic performance of the Chinese frontal assessment battery in early cognitive impairment in an Asian population. Dement Geriatr Cogn Disord 2010;30:525–32. 10.1159/000321665. 21252547.
37. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud 1988;10:61–3. 10.3109/09638288809164103. 3403500.
38. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86. 10.1093/geront/9.3_part_1.179. 5349366.
39. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–14. 10.1212/wnl.44.12.2308. 7991117.
40. Sahadevan S, Lim JP, Tan NJ, Chan SP. Psychometric identification of early Alzheimer disease in an elderly Chinese population with differing educational levels. Alzheimer Dis Assoc Disord 2002;16:65–72. 10.1097/00002093-200204000-00003. 12040301.
41. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45. 10.2307/2531595. 3203132.
42. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32–5. 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. 15405679.
43. Wetzel AP. Factor analysis methods and validity evidence: a review of instrument development across the medical education continuum. Acad Med 2012;87:1060–9. 10.1097/ACM.0b013e31825d305d. 22722361.
44. Mardh S, Karlsson T, Marcusson J. Aspects of awareness in patients with Alzheimer's disease. Int Psychogeriatr 2013;25:1167–79. 10.1017/s1041610212002335. 23425334.
45. Horning SM, Melrose R, Sultzer D. Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances. Int J Geriatr Psychiatry 2014;29:77–84. 10.1002/gps.3972. 23671016.
46. Lim JP, Lau S, Lun P, Tang JY, Chan ES, Shi L, et al. Optimising dementia screening in community-dwelling older adults: a rapid review of brief diagnostic tools in Singapore. Ann Acad Med Singap 2024;53:742–53. 10.47102/annals-acadmedsg.2024163. 39748173.
47. Gao J, Lun P, Lau LK, Tan WS, Tan E, Lim WS, et al. Developing a Delphi consensus on the domains and conduct of brief geriatric assessments in Singapore. Ann Geriatr Med Res 2025;29:177–84. 10.4235/agmr.24.0198. 39967564.
48. Vargas-Gonzalez JC, Chadha AS, Castro-Aldrete L, Ferretti MT, Tartaglia MC. Informant characteristics influence clinical dementia rating sum of boxes scores-based staging of Alzheimer's disease. Nat Aging 2024;4:1538–43. 10.1038/s43587-024-00732-x. 39455890.
49. Abken E, Ferretti MT, Castro-Aldrete L, Santuccione Chadha A, Tartaglia MC. The impact of informant-related characteristics including sex/gender on assessment of Alzheimer's disease symptoms and severity. Front Glob Womens Health 2024;5:1326881. 10.3389/fgwh.2024.1326881. 38605937.
50. Ham Y, Bae S, Lee H, Ha Y, Choi H, Park JH, et al. Item-level psychometrics of the ascertain dementia eight-item informant questionnaire. PLoS One 2022;17e0270204. 10.1371/journal.pone.0270204. 35789335.

Article information Continued

Fig. 1.

Comparison of AUC of AD8-Self versus AD8-Informant between two groups: (A) early cognitive impairment, (B) mild cognitive impairment. AUC, area under the curve; AD8-Self, Ascertain Dementia 8-item Questionnaire-Self reported; AD8-Informant, Ascertain Dementia 8-item Questionnaire-Informant reported.

Table 1.

Summary of studies on AD8 performance and factor structure in Asian population

Study, year Setting (Country) Type of AD8 CDR=0.5 CDR≥0.5 Reliability (Cronbach's α) Factor analysis (Yes/No)
Wang et al.,5) 2023 Community setting (China) AD8-Informant MCI CDR=0.5 Dementia CDR ≥1 0.67 Yes (confirmatory factor analysis)
Cutoff score ≥2, Sen 50.5%, Spe 78% Cutoff score ≥3, Sen 90.9%, Spe 89%
Ryu et al.,6) 2009 Memory clinic (Korea) AD8-Informant MCI+very early dementia CDR=0.5 Dementia CDR≥0.5 0.88 No
Cutoff score ≥1, Sen 81%, Spe 65% Cutoff score ≥2, Sen 78%, Spe 90%
Cutoff score ≥2, Sen 68%, Spe 90%
Cutoff score ≥3, Sen 53%, Spe 95%
Meguro et al.,7) 2015 Community (Japan) AD8-Informant - Dementia CDR≥1 0.88 No
Cutoff score ≥2, Sen 88.4%, Spec 68.4%
Cai et al.,9) 2021 Community (China) AD8-Self MCI CDR=0.5 Dementia CDR≥1 - No
Cutoff score ≥2, Sen 48.8%, Spe 72% Cutoff score ≥2, Sen 100%, Spe 72%
Dominguez et al.,10) 2021 Community (Philippine) AD8-Informant - Dementia CDR≥1 - No
Cutoff score ≥3, Sen 91.5%, Spe 77.9%
Cutoff score ≥4, Sen 83%, Spe 90.6%
Li et al.,11) 2012 Memory clinic (China) AD8-Informant - Dementia CDR≥1 0.78 No
Cutoff score ≥2, Sen 93.9%, Spe 76%
Chin et al.,12) 2013 Memory clinic (Singapore) AD8-Self MCI CDR=0.5 Cognitive impairment No
Cutoff score ≥1, Sens 84%, Spe 65% Cutoff score ≥1, Sen 85%, Spe 74%
Cutoff score ≥2, Sens 67%, Spe 90% Cutoff score ≥2, Sen 73%, Spe 80%
Cutoff score ≥3, Sens 55%, Spe 83% Cutoff score ≥3, Sen 59%, Spe 85%
Chio et al.,16) 2017 Out-patient neurology clinic (Taiwan) AD8-Informant - MCI+Mild dementia CDR ≥0.5 0.86 No
Cutoff score ≥1, Sen 93%, Spe 33%
Cutoff score ≥2, Sen 88%, Spe 37%
Cutoff score ≥3, Sen 82%, Spe 53%
Cutoff score ≥4, Sen 71%, Spe 63%
AD8-Self - MCI+Mild dementia CDR ≥0.5 0.68 No
Cutoff score ≥1, Sen 81%, Spe 28%
Cutoff score ≥2, Sen 55%, Spe 63%
Cutoff score ≥3, Sen 32%, Spe 79%
Cutoff score ≥4, Sen 16%, Spe 86%
Dong et al.,17) 2013 Memory clinic (Singapore) AD8-Informant MCI CDR=0.5 MCI+Dementia CDR ≥0.5 0.76 No
Cutoff score ≥2, Sen 81.5%, Spe 86.5% Cutoff score ≥2, Sen 92.6%, Spe 86.5%
AD8-Self MCI CDR=0.5 MCI+Dementia CDR ≥0.5 0.66 No
Cutoff score ≥2, Sen 56.9%, Spe 64.9% Cutoff score ≥2, Sen 59.3%, Spe 64.9%
Kan et al.,20) 2019 Population-based study (Singapore) AD8-Informant Very mild dementia CDR=0.5 Dementia CDR≥1 - No
Cutoff score ≥1, Sens 62%, Spe 73% Cutoff score ≥3, Sen 76%, Spe 94%
Tew et al.,21) 2015 Memory clinic (Singapore) AD8-Informant - Mild dementia CDR ≤1 - No
Cutoff score ≥6, Sen 90.7%, Spe 84.3%
Kasai et al.,22) 2021 Community (Japan) AD8-Self - MCI+Mild dementia CDR ≥0.5 0.71 No
Cutoff score ≥1, Sen 85.5%, Spe 45.7%
Cutoff score ≥2, Sen 70.7%, Spe 65.7%
AD8-Informant - MCI+Mild dementia CDR ≥0.5 - No
Cutoff score ≥1, Sen 65.5%, Spe 54.3%
Cutoff score ≥2, Sen 37.9%, Spe 88.6%
Yang et al.,23) 2011 Out-patient neurological clinic (Taiwan) AD8-Informant Very mild dementia CDR=0.5 Dementia CDR≥1 - No
Cutoff score ≥2, Sens 95.9%, Spe 78.1% Cutoff score ≥2, Sen 97.6%, Spe 78.1%
Shaik et al.,24) 2015 Primary care (Singapore) AD8-Informant - - 0.85-0.91 No
Chan et al.,25) 2016 Primary care (Singapore) AD8-Informant - Dementia CDR≥1 - No
Cutoff score ≥4, Sen 91%, Spe 91%
Kim et al.,26) 2019 Out-patient clinic (Korea) AD8-Self - Dementia CDR≥1 - No
Cutoff score ≥2, Sen 71%, Spe 75%
Cutoff score ≥3, Sen 61%, Spe 89%
Tak et al.,27) 2021 Tertiary clinic (India) AD8-Informant - ICD-10 dementia - No
Cutoff score ≥3, Sen 48.89%, Spe 67.58%
Cutoff score ≥4, Sen 100%, Spe 99.86%

AD8-Self, Ascertain Dementia 8-item Questionnaire-self reported; AD8-Informant, Ascertain Dementia 8-item Questionnaire-informant reported; CDR, Clinical Dementia Rating; ICD-10, International Classification of Diseases 10th Revision; MCI, mild cognitive impairment; Sen, sensitivity; Spe, specificity.

Table 2.

Baseline characteristics of study cohort (n=515)

Characteristic Normal (n=43) MCI (n=102) ECI=MCI+Mild dementia (n=472) p-value
Age (y) 69.28±7.87 72.61±7.09a) 75.61±6.9b,c) <0.01
Female sex 26 (60.5) 52 (51.0) 277 (58.7) 0.198
Education level (y) 9.58±4.83 6.82±4.8a) 5.6±4.9b) <0.01
Ethnic group 0.788
 Chinese 40 (93) 94 (92.2) 432 (91.5)
 Malay 2 (4.7) 3 (2.9) 17 (3.6)
 Indian 1 (2.3) 3 (2.9) 19 (4)
 Others 0 (0) 2 (2.0) 4 (0.8)
Disease variable
 AMT 9.42±1.03 8.65±1.56 7±2.2b,c) <0.01
 m-CMMSE 25.47±2.36 23.29±3.75 19.1±4.8b,c) <0.01
 BADL 99.19±2.87 97.84±4.53 96.45±7.1b) 0.001
 IADL 20.30±3.90 18.60±3.77 15.10±4.80b,c) <0.01
 NPI-Q Severity 2.13±2.35 2.84±3.20 3.60±3.70 0.197
 NPI-Q CG Distress 1.42±2.80 2.86±4.66 3.80±5.50 0.446
 AD8-Self 1.74±1.20 2.39±1.72 2.40±1.80 0.097
 AD8-Informant 1.67±1.25 3.38±2.07a) 5.29±2.04b,c) <0.01

Values are presented as mean±standard deviation or frequency (%).

MCI, mild cognitive impairment; ECI, early cognitive impairment; AMT, Abbreviated Mental Test; m-CMMSE, modified Chinese Mini-Mental Status Examination; BADL, Barthel Index of basic activities of daily living; IADL, instrumental activities of daily living; NPI-Q, Neuropsychiatric Inventory Questionnaire; NPI-Q CG Distress, Neuropsychiatric Inventory Questionnaire Caregiver Distress; AD8, Ascertain Dementia 8-item Questionnaire.

Post hoc comparison with Bonferroni correction (p<0.05):

a)

Normal vs. MCI,

b)

Normal vs. Mild dementia,

c)

MCI vs. Mild dementia.

Table 3.

Reliability and diagnostic performance of AD8-Self vs. AD8-Informant

Cronbach's α Sensitivity Specificity PPV NPV AUC
ECI
 AD8-Self (cutoff score ≥4) 0.666 0.270 0.953 0.985 0.106 0.593
 AD8-Informant (cutoff score ≥3) 0.764 0.890 0.791 0.979 0.395 0.915
MCI
 AD8-Self (cutoff score ≥4) 0.663 0.265 0.953 0.931 0.353 0.600
 AD8-Informant (cutoff score ≥3) 0.709 0.647 0.791 0.880 0.486 0.745

AD8-Self, Ascertain Dementia 8-item Questionnaire-Self reported; AD8-Informant, Ascertain Dementia 8-item Questionnaire-Informant reported; ECI, early cognitive impairment; MCI, mild cognitive impairment; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve.

Table 4.

Factor structure of AD8-Self vs. AD8-Informant

Questionnaire AD8-Self AD8-Informant
Mean Factor 1 (non-memory domain) Factor 2 (memory domain) Mean Factor 1
1. Daily problem with thinking and/or memory 0.73 -0.012 0.840 0.940 0.535
2. Trouble remembering appointments 0.42 0.215 0.673 0.760 0.717
3. Repeats the same things over and over 0.59 0.227 0.685 0.770 0.606
4. Forgets correct week or month or year 0.22 0.447 0.252 0.610 0.718
5. Less interest in hobbies/activities 0.15 0.526 0.097 0.420 0.538
6. Trouble learning how to use a tool, appliance, or gadget 0.17 0.713 0.098 0.500 0.578
7. Trouble handling complicated financial affairs 0.16 0.721 0.024 0.540 0.665
8. Problems with judgment 0.12 0.487 0.162 0.460 0.580
p-value <0.0001 <0.0001

Bold font indicates item with high factor loading.

AD8-Self, Ascertain Dementia 8-item Questionnaire-Self reported; AD8-Informant, Ascertain Dementia 8-item Questionnaire-Informant reported.